Target intelligence / Profile preview

Tumor cell stress-induced ligands and danger-associated molecular patterns (DAMPs)

Target
DAMPs
Molecular classification
Other, Ligand, Chaperone, Nucleotide
01

Overview

Tumor cell stress-induced ligands and danger-associated molecular patterns (DAMPs) are a heterogeneous class of endogenous molecules that serve as critical signals for the immune system to recognize and eliminate stressed or dying malignant cells (Galluzzi et al., 2020, Nature Reviews Immunology). These molecules include surface-exposed proteins like calreticulin, secreted factors like HMGB1 and ATP, and stress-induced surface ligands such as MICA and MICB (Kroemer et al., 2022, Science). Under normal conditions, these molecules are intracellular or absent, but they are upregulated or released in response to genomic instability, metabolic stress, or cytotoxic therapy. They function by binding to specific receptors on innate immune cells—such as TLR4, P2RX7, and NKG2D—thereby facilitating the recruitment and activation of dendritic cells and natural killer cells (Raulet et al., 2013, Annual Review of Immunology). This process, often termed immunogenic cell death (ICD), is essential for the efficacy of many conventional cancer treatments, including anthracyclines and radiotherapy. However, the therapeutic challenge lies in the dual nature of these signals, as chronic DAMP signaling can sometimes promote a pro-tumorigenic inflammatory environment (Zitvogel et al., 2016, Cell).

Other names
Damage-associated molecular patternsAlarminsICD-associated moleculesStress-induced ligandsEndogenous danger signals
02

Mechanism of action

Induction of immunogenic cell death (ICD) and activation of pattern recognition receptors (PRRs) to stimulate anti-tumor immunity.

03

Biological functions

Immune responseCell deathSignal transductionInflammation
04

Disease associations

CancerInflammationAutoimmunity
05

Safety considerations

Cytokine release syndromeAutoimmune toxicityChronic inflammation-driven tumor progression
06

Interacting drugs

Doxorubicin

6 more in the full profile.

07

Biomarkers

Surface-exposed calreticulin (ecto-CRT)Extracellular ATP levelsHigh mobility group box 1 (HMGB1) releaseType I Interferon signature

Beyond the preview

Go deeper on Tumor cell stress-induced ligands and danger-associated molecular patterns (DAMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor cell stress-induced ligands and danger-associated molecular patterns (DAMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call